Traded Nov 25, 2025 · Filed Nov 28, 2025
A board member of Quest Diagnostics sold $240K of Quest Diagnostics shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$239,700
Shares × reported transaction price
35 days after results of Oct 21, 2025, 48 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $192.35 on Nov 25, 2025, at its 52-week high, after a 4% rise over the previous 30 trading days
52-week range $150.33 (Jan 15, 2025) to $192.35 (Nov 25, 2025), 100% of the way up, from 250 adjusted closes. 30 trading days earlier: $185.39 on Oct 14, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.1% | +0.5% | −1.6% |
| 30 days | −5.6% | +0.2% | −5.8% |
| 90 days | +14.4% | +0.9% | +13.5% |
| 180 days | +4.6% | +11.5% | −6.9% |
Past results only. Not a forecast.
Julie Johnson soldDemocrat, Representative, TX district 32Held by the filer's joint per the disclosure. Disclosed 38 days after the transaction; reported as an official range, not an exact amount.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$1.79M of Quest Diagnostics
Scheduled in advance